<https://rdf.molmedb.upol.cz/reference/ref3863> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492215>;
	<http://purl.org/ontology/bibo/pmid> "21840218"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492864>,
		<https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM492719>,
		<https://identifiers.org/molmedb/MM492823>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2011.06.114"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Scheiper B, Matter H, Steinhagen H, Böcskei Z, Fleury V, McCort G.: Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors. Bioorg Med Chem Lett, Volume 21 (18), 2011"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1029403> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3863> .
<https://rdf.molmedb.upol.cz/interaction/int1029332> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3863> .
<https://rdf.molmedb.upol.cz/interaction/int1027624> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3863> .
<https://rdf.molmedb.upol.cz/interaction/int1029070> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3863> .